Piecing together the Pediatric Brain Tumor Puzzle

Forget, 2018, Aberrant ERBB4-SRC signaling as a hallmark of Group 4 medulloblastoma revealed by integrative phosphoproteomic profiling, Cancer Cell, 34, 379, 10.1016/j.ccell.2018.08.002 Rivero-Hinojosa, 2018, Proteomic analysis of Medulloblastoma reveals functional biology with translational potential, Acta Neuropathol. Commun., 6, 48, 10.1186/s40478-018-0548-7 Petralia, 2020, Integrated proteogenomic characterization across major histological types of pediatric brain cancer, Cell, 183, 1962, 10.1016/j.cell.2020.10.044 Capper, 2018, DNA methylation-based classification of central nervous system tumours, Nature, 555, 469, 10.1038/nature26000 Huether, 2014, The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes, Nat. Commun., 5, 3630, 10.1038/ncomms4630 Morrissy, 2016, Divergent clonal selection dominates medulloblastoma at recurrence, Nature, 529, 351, 10.1038/nature16478 Eleveld, 2015, Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations, Nat. Genet., 47, 864, 10.1038/ng.3333 Bouffet, 2016, Immune checkpoint inhibition for hypermutant glioblastoma multiforme resulting from germline biallelic mismatch repair deficiency, J. Clin. Oncol., 34, 2206, 10.1200/JCO.2016.66.6552 Venkatesh, 2019, Electrical and synaptic integration of glioma into neural circuits, Nature, 573, 539, 10.1038/s41586-019-1563-y Ryall, 2020, Integrated molecular and clinical analysis of 1,000 pediatric low-grade gliomas, Cancer Cell, 37, 569, 10.1016/j.ccell.2020.03.011